Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. - Wikidata - wikimedia - TriplyDB

Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production.

Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production.

http://www.wikidata.org/entity/Q41908710

about

Inducing and Administering Tregs to Treat Human Disease Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation In vivo bioluminescent imaging (BLI): noninvasive visualization and interrogation of biological processes in living animals The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation.Effects of rapamycin combined with low dose prednisone in patients with chronic immune thrombocytopenia.Targeting Janus tyrosine kinase 3 (JAK3) with an inhibitor induces secretion of TGF-β by CD4+ T cells.IL-2-Mediated In Vivo Expansion of Regulatory T Cells Combined with CD154-CD40 Co-Stimulation Blockade but Not CTLA-4 Ig Prolongs Allograft Survival in Naive and Sensitized Mice Current and future approaches for control of graft-versus-host disease.Regulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune Homeostasis Immunoregulatory functions of mTOR inhibition.Nfatc2 and Tob1 have non-overlapping function in T cell negative regulation and tumorigenesis Can antigen-specific regulatory T cells protect against graft versus host disease and spare anti-malignancy alloresponse?Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantation The biology of graft-versus-host disease: experimental systems instructing clinical practice.Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapy A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease.Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease.Pathogenesis and management of graft-versus-host disease.The role of the thymus in tolerance.Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.Contradictory immune response in post liver transplantation hepatitis B and C.Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.Mesenchymal stromal cells transiently alter the inflammatory milieu post-transplant to delay graft-versus-host disease Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance.Renal transplantation in patients with sarcoidosis: a French multicenter study Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer.Mechanisms of cyclic nucleotide phosphodiesterases in modulating T cell responses in murine graft-versus-host disease.A diagnostic window for the treatment of acute graft-versus-host disease prior to visible clinical symptoms in a murine model.Generation of human regulatory T cells de novo with suppressive function prevent xenogeneic graft versus host disease.HDAC inhibition and graft versus host disease Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activity.Inhibition of calcineurin abrogates while inhibition of mTOR promotes regulatory T cell expansion and graft-versus-host disease protection by IL-2 in allogeneic bone marrow transplantation In vivo cell tracking with bioluminescence imaging.Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation Phase I trial of adoptive cell transfer with mixed-profile type-I/type-II allogeneic T cells for metastatic breast cancer.Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease.Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells.Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation.HY-Specific Induced Regulatory T Cells Display High Specificity and Efficacy in the Prevention of Acute Graft-versus-Host Disease

P2860

Q26772723-DBACEE3A-DC01-4453-B8DB-DE01870380E9 Q26784460-A499B6A8-84E6-4C02-8E2B-68E3F79A74FA Q27006069-63E6F9D5-F92A-4392-BD67-C17CF5C59240 Q28076264-93D4979E-6376-4F08-A1AA-8B2A749F3AE3 Q33381227-72F170CF-8641-49FD-A781-105D5D666D5F Q33412264-84847847-ACD6-49C0-AECF-F73B786DEDDA Q33577441-D100376F-F3BF-44DC-BE1E-9517C86F5CDD Q33586165-44A07EB3-2560-4E11-B164-621D26500C20 Q33642625-95F4BCC9-E664-4B2C-AE62-AB4171596F80 Q33729446-C9CD4BE3-4C67-4DD5-B491-373A734EDC92 Q33761278-76B2E663-D5D6-4D9C-81B3-356287966D37 Q33779715-FC957025-D8BD-40A9-A483-7AB94791B3BC Q33800533-3C78C1DC-D5DC-47E7-82AA-7E7AB59E2B91 Q33898020-55F8E46D-1409-4BE2-8569-8D0E931139AD Q33917175-76A24A14-3F8D-4BC2-AF5F-D5C39AB51CCB Q33917765-A720B705-580D-4121-9847-4E04264DC77E Q33964687-768F5D62-9B69-4038-BCCE-3B2E30CDB62A Q34044170-B266AB26-3971-4A65-8BF5-4B658FCD6F6D Q34077479-AB39B24F-A143-484D-B03E-24A27D30684D Q34103905-7146F423-1519-4568-BC9C-EDB8BB3CC72A Q34144161-1F7DC3A2-AB20-4AEB-9309-5A2D3599AC82 Q34152074-BFCD3B09-2150-4A94-9714-9F2073E010DA Q34279929-FD9A47B3-2524-4A01-B614-8AB3C4AD835E Q34371122-36264998-C47D-44CF-B217-EF4AD308D859 Q34400439-C5B4BEE2-1FD0-4E73-9302-CDE1BF9E3A8C Q34405427-5D5FF54F-744A-4AA8-BD8D-ED1756C291C4 Q34536661-E8D53670-D356-472F-9A55-52B696B581FE Q34618635-2AB1D2AE-19E6-4B72-AD92-116C04ED611D Q34732865-0046A053-DE06-40D1-9EF4-D0CCB62FF82C Q34996186-17EB0402-1ED7-4494-A0B0-9D85BFAB84F3 Q35016985-A4DD30B4-F1BE-4B70-8985-027746FEA601 Q35037993-A2D057DE-90FC-4F54-BD8F-C64866E0551F Q35128301-A79847A2-CB89-4D5A-A71B-F4C572517E83 Q35162679-7A2FF4B2-F21C-4271-8275-717BC1DA16EA Q35184589-CC8F741F-305F-4C60-9F93-6285EDFFD231 Q35510507-2BF1733E-7C28-4E85-89DF-825E5A6EF88E Q35642843-87393222-19B9-4225-B0F3-DC8BC267805B Q35743830-99105B27-6F8C-43A2-92CB-B31C2BD44697 Q35750957-75ED2D56-893B-447C-A3A5-C7D489F2AB40 Q35815893-7BEA3593-44F2-4981-839C-3C6F21B40766

P2860

Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production.

http://www.wikidata.org/entity/Q41908710

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Inhibition of CD4+CD25+ regula ...... dent interleukin-2 production.

@en

type

label

Inhibition of CD4+CD25+ regula ...... dent interleukin-2 production.

@en

prefLabel

Inhibition of CD4+CD25+ regula ...... dent interleukin-2 production.

@en

P1433

Q41908710-58142B20-83DA-444B-869D-0E51E1248D15

P1476

Q41908710-0E9586E1-552D-467D-8C4C-51D83FD2A8E8

P2093

Q41908710-1D32FE56-6EEF-4C50-B879-A8F3CAEF2DCF

Q41908710-225DB637-490D-4F5C-96EC-82018E781628

Q41908710-4B9F272F-1149-4691-B8E6-136BC6A71465

Q41908710-AC7E97C2-11DC-405D-8FAC-838D700F531B

Q41908710-B79E127A-E478-4303-8EB8-CFB3F74CDF16

Q41908710-E70F5C07-2329-4397-8E30-E904F6F98738

Q41908710-F9464183-3F75-4321-9D7D-D0B36658E06C

P2860

Q41908710-0654905B-B76C-4594-BD5E-6A946129FF43

Q41908710-08EAA7D9-8DD1-44E8-A113-D4F149F41C81

Q41908710-0A500BF9-5AD2-4F45-A096-5517CF7CF29D

Q41908710-0CD64BC8-C638-41D6-BE40-B60706C2F319

Q41908710-202E0080-0ABC-4EBF-AF11-2694B5F3C6EC

Q41908710-2674EEEF-0C4B-4192-BF0A-66232BF92C3F

Q41908710-3134A94C-9251-47A0-A2D5-11EA71BFF122

Q41908710-32E9017F-B2FF-4A73-8C76-A4024893CF59

Q41908710-3C7B548B-5254-4A68-AF69-D52E5A3C87F2

Q41908710-43F4F12E-78A3-4A89-B591-284FE114ECF5

P304

Q41908710-77C696F6-2542-4DF2-AF3E-91AED09B5BEE

P31

Q41908710-96F8E888-F5FD-44EA-B1D5-C814E34FB72E

P356

Q41908710-0BFE99FE-D4F4-4C3B-820F-43F50D0FBA18

P407

Q41908710-B47876A9-EBCD-4460-89E8-6ED73BDBC346

P433

Q41908710-1A87636B-E48F-45E5-A941-8E0906FB5CDF

P478

Q41908710-FFB71B75-3031-4C39-BCDD-F4984103F20F

P50

Q41908710-E2C295AA-245E-4922-90D2-B5A18461722B

P577

Q41908710-852E2636-E268-4BB2-9575-03C5932AB73B

P5875

Q41908710-3EA8EBF1-BC9A-47C1-81E6-BC04A88F7C7E

P698

Q41908710-6A1E03E4-AFDB-4025-BC44-2B4C36765F24

P932

Q41908710-93CC8C78-E276-487D-AB5F-46843BCB00C2

P356

BLOOD-2006-01-0329

P1433

P1476

Inhibition of CD4+CD25+ regula ...... dent interleukin-2 production.

@en

P2093

Andreas Beilhack

http://www.w3.org/2001/XMLSchema#string

Jeanette Baker

http://www.w3.org/2001/XMLSchema#string

Martin Buess

http://www.w3.org/2001/XMLSchema#string

Robert S Negrin

http://www.w3.org/2001/XMLSchema#string

Robert Zeiser

http://www.w3.org/2001/XMLSchema#string

Stephan Schulz

http://www.w3.org/2001/XMLSchema#string

Vu H Nguyen

http://www.w3.org/2001/XMLSchema#string

P2860

Control of regulatory T cell development by the transcription factor Foxp3

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

Determination of lymphocyte division by flow cytometry

A function for interleukin 2 in Foxp3-expressing regulatory T cells

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia

Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).

Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.

Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.

Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.

P304

390-399

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2006-01-0329

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Christopher H. Contag

P577

2006-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7255111

http://www.w3.org/2001/XMLSchema#string

P698

16522809

http://www.w3.org/2001/XMLSchema#string

P932

1895845

http://www.w3.org/2001/XMLSchema#string